Delivery Order SPE2DB20D3103-SPE2DB25FL3Y0

Award Date 10/17/24
Potential Completion Date 10/18/24
Potential Value $8.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,373.43 firm fixed price delivery order is for the supply of RECTIV 0.4% ointment, a pharmaceutical product. The contract has an ultimate completion date of March 24, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,287.63 firm fixed-price delivery order is for the supply of RECTIV 0.4% OINTMENT 30GM, a medical product. The award has an ultimate completion date of June 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,608.68 firm fixed-price delivery order is for the supply of RECTIV 0.4% OINT 1S medical products. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,236.97 firm fixed-price delivery order is for the supply of "RECTIV 0.4% OINTMENT 30GM" medical products. The contract has an ultimate completion date of June 12, 2024 and was awarded on June 11, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The Delivery Order, valued at $9,952.24, is for the supply of 4563472984 RECTIV 0.4% OINTMENT 30GM to support federal government healthcare programs. The award has a completion date of January 30, 2024 and is a Firm Fixed Price contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4568082307 RECTIV 0.4% OINTMENT 30GM. The $1,345.90 contract has a performance period through May 1, 2025. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle through December 2026....
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is a Delivery Order (SPE2DB20D1100|SPE2DB24FD9X1) valued at $1,831.65 for the supply of 4565921481 ! RECTIV 0.4% OINTMENT 30GM. The award was made by the Defense Logistics Agency (DLA), a defense agency, on September 24, 2024, with an ultimate completion date of September 25, 2024. This appears to be a Firm Fixed Price contract for the delivery of pharmaceutical products. There is no set-aside designation...
This federal contract award SPE2DB20D1047|SPE2DB25FF32V, valued at $2,386.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RECTIV 0.4% OINTMENT 30GM, a pharmaceutical product, with a completion date of December 16, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,042.82, is for the delivery of RECTIV 0.4% OINTMENT 30GM medical supplies. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of June 26, 2024. The contract was awarded on June 25, 2024 and has no set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,528.97, is for the delivery of RECTIV 0.4% ointment in 30-gram quantities. The contract is a firm fixed-price, non-set-aside award with a period of performance through May 2, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FL3Y0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,062.14 firm fixed-price delivery order is for the supply of 4566134271 - RECTIV 0.4% OINTMENT 30GM, with a completion date of October 18, 2024.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies across various federal agencies and programs.

Generated 2/27/25, 11:29 AM